Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Coming of Age of Nucleic Acid Vaccines during COVID-19
Halie M. Rando, Ronan Lordan, Likhitha Kolla, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 13

Showing 13 citing articles:

The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
Bowen Lu, Jing Ming Lim, Boyue Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 36
Coccidioidomycosis and Histoplasmosis in Immunocompetent Persons
John N. Galgiani, Carol A. Kauffman
New England Journal of Medicine (2024) Vol. 390, Iss. 6, pp. 536-547
Closed Access | Times Cited: 21
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 16
Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
Thomas E. Hickey, Uma Mudunuri, Heidi Hempel, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Targeting Enterotoxins: Advancing Vaccine Development for Enterotoxigenic Escherichia coli ETEC
Josune Salvador-Erro, Yadira Pastor, Carlos Gamazo
Toxins (2025) Vol. 17, Iss. 2, pp. 71-71
Open Access
In-vitro evaluation of cationic Lipopeptides as adjuvant candidate for DNA plasmid vaccine
Syahrul Febrian Hasbullah, Ace Tatang Hidayat, Tarwadi, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130183-130183
Closed Access
Application of Traditional Vaccine Development Strategies to SARS-CoV-2
Halie M. Rando, Ronan Lordan, Alexandra Lee, et al.
mSystems (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 14
Milk polar lipids: Untapped potential for pharmaceuticals and nutraceuticals
Aditi Pawar, Ioannis Zabetakis, Tanvi Gavankar, et al.
PharmaNutrition (2023) Vol. 24, pp. 100335-100335
Closed Access | Times Cited: 11
Spherical nucleic acids-based nanoplatforms for tumor precision medicine and immunotherapy
Songbin Liu, Cui‐Yun Yu, Hua Wei
Materials Today Bio (2023) Vol. 22, pp. 100750-100750
Open Access | Times Cited: 8
Prophylactic and therapeutic vaccine development: advancements and challenges
Induni Nayodhara Weerarathna, Elijah Skarlus Doelakeh, Lydia Kiwanuka, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
The potential cardioprotective bioactive compounds in fermented alcoholic beverages: Mechanisms, challenges, and opportunities in beer and wine
Sakshi Hans, Ioannis Zabetakis, Ronan Lordan
Nutrition Research (2024) Vol. 133, pp. 108-126
Closed Access | Times Cited: 1
Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial
Xavier Sáez‐Llorens, Ximena Norero, Marisa Márcia Mussi‐Pinhata, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. 1, pp. 95-107
Open Access | Times Cited: 4
Influenza B Virus Vaccine Innovation through Computational Design
Matthew J. Pekarek, Eric A. Weaver
Pathogens (2024) Vol. 13, Iss. 9, pp. 755-755
Open Access
Adeno-associated viral vectors deliver gene vaccines
Lai Wei, Peng Yu, Haomeng Wang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117010-117010
Closed Access
Page 1

Scroll to top